An unusual earnings report that revealed its usually predictable and profitable Biological Indicators division had underperformed, resulted in Mesa Laboratories (MLAB) taking a big hit over a three-day period, dropping from $67.33 on August 6, 2013 to $58.79 on the close of trading on August 9, 2013.
As the anomaly was understood by investors, the share price started to rebound, already soaring almost 5% on Monday, August 12, 2013, to close at $61.63 per share. Having dropped just under 14%, there is still a lot of upside in the near term, and over the long term will continue on its upward run.
With the incident leading to the miss in the latest quarter having already been taken care...
Only subscribers can access this article, which is part of the PRO research library covering 3,577 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: